⌘K

Home/Filings/4/0001181431-10-008925

4//SEC Filing

Stark David 4

Accession 0001181431-10-008925

CIK 0001360479other

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 7:37 AM ET

Size

5.4 KB

Accession

0001181431-10-008925

Insider Transaction Report

Form 4

Period: 2010-02-11

Stem Cell Therapy International, Inc.SCII

DirectorPresident

Transactions

Award
Common Stock Option
2010-01-04$0.11/sh+500,000$55,000→ 2,250,000 total
Exercise: $0.11From: 2010-01-04Exp: 2020-01-04→ Common Stock (500,000 underlying)

Documents

1 file

4
rrd266018.xmlPrimary
FORM 4

Issuer

Stem Cell Therapy International, Inc.

CIK 0001360479

Entity typeother

Related Parties

1

filerCIK 0001442436

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 7:37 AM ET
Size: 5.4 KB

View on SEC.gov